MedPath

Randomized controlled trial of 4-hour versus 24-hour nasogastric rehydration in children with acute gastroenteritis and moderate dehydratio

Not Applicable
Completed
Conditions
Acute viral gastroenteritis with moderate dehydration
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Registration Number
ACTRN12610000737033
Lead Sponsor
Royal Children's Hospital Melbourne
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
426
Inclusion Criteria

Children with acute gastroenteritis and moderate dehydration presenting to the Emergency Department at 2 metropolitan paediatric teaching hospitals

Acute diarrhoea (non-bloody)

Moderate dehydration defined as 3 clinical signs (based on Gorelick study criteria)

Exclusion Criteria

1 - Bloody diarrhoea,
2 - Severe dehydration (dehydration score > 7)
3 - Mild dehydration (dehydration score < 3)
4 - Unable to obtain written informed consent,
5 - Patient living outside area covered by hospital-in-the-home (part of follow-up at 24 hrs and 7 days)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical treatment failure of rehydration schedules defined as >2% body weight from time of admission after randomisation<br>Main outcome measures: body weight[Admission to Emergency Department (enrolment and randomisation)<br><br>Reviews and measurement of body weight at 4-6 hours, 24 hours and 7 days from time of randomisation]
Secondary Outcome Measures
NameTimeMethod
Secondary treatment failure is defined as:<br>1 - need for hospital admission at any time point after rapid rehydration (4 hrs), or re-admission after discharge from hospital for standard rehydration (24 hrs) <br>2 - need for insertion of intravenous (IV) cannula for IV rehydration for either rehydration schedule at any time point after randomisation[Admission to Emergency Department (enrolment and randomisation)<br><br>Reviews at 4-6 hours, 24 hours and 7 days from time of randomisation]
© Copyright 2025. All Rights Reserved by MedPath